// App-Quantinova.ai

1393 : The Regulation Of Central Nervous System Acute Lymphoblastic Leukemia By Natural Killer Cells

Researchers

Presenter

  • Liron Frishman-Levy

Principal Investigators

  • Avishai Shemesh

  • Shahar Frenkel

  • Shai Izraeli

  • Allan Bar-Sinai

  • Zhenya Ni

  • Dan S. Kaufman

  • Lueder Hinrich Meyer

  • Gunnar Cario

  • Jacob Hochman

  • Angel Progador

Medical Centers

  • Ocular Oncology Service, Department of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  • Department of Medicine, University Medical Center Schleswig-Holstein, Kiel, Germany

  • National Institute for Biotechnology in the Negev (NIBN), Ben-Gurion University of the Negev, Beer Sheva, Israel

  • The Shraga Segal Department of Microbiology and Immunology, Ben-Gurion University of the Negev, Beer Sheva, Israel

  • Department of Developmental and Cell Biology, Hebrew University, Jerusalem, Israel

  • Department of Medicine and Stem Cell Institute, University of Minnesota, Minneapolis, MN

  • Department of Human Genetics and Biochemistry, Tel Aviv University, Tel Aviv, Israel

  • Department of Medicine and Stem Cell Institute, University of Minnesota, Minneapolis, MN

  • Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel

  • Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany

Locations

  • United States

  • Germany

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Natural Killer cells

  • Breakpoint Cluster Region

  • Interleukin-15

  • Natural killer group 2D

Drug/Treatment

  • IL-15

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved